Laboratory News and Research

RSS

New study indicates that cancer patients rarely push for unnecessary tests, treatments

Physicians often blame patient demands for contributing to high medical costs, however, a new study involving more than 5,000 patient-clinician visits indicates that cancer patients rarely push for unnecessary tests and treatments from their health care providers.

16 Feb 2015

A*STAR's GIS scientists develop new system that can predict treatment targets for cancer

In recent months, several national initiatives for personalized medicine have been announced, including the recently launched precision medicine initiative in the US, driven by rapid advances in genomic technologies and with the promise of cheaper and better healthcare. Significant challenges remain, however, in the management and analysis of genetic information and their integration with patient data.

15 Feb 2015

Recipients of 2015 AACC and NACB Awards announced

AACC and its academy, the National Academy of Clinical Biochemistry, are pleased to announce the recipients of the 2015 AACC and NACB Awards, which honor laboratory medicine professionals worldwide for advancing the field of clinical laboratory testing.

14 Feb 2015

Declarative memory helps individuals with neurodevelopmental disorders compensate for dysfunction

Individuals with five neurodevelopmental disorders -- autism spectrum disorder, obsessive-compulsive disorder, Tourette syndrome, dyslexia, and Specific Language Impairment -- appear to compensate for dysfunction by relying on a single powerful and nimble system in the brain known as declarative memory.

13 Feb 2015

Immune system exploits flu virus' dependence on host's machinery

Viruses are masters of outsourcing, entrusting their fundamental function - reproduction - to the host cells they infect. But it turns out this highly economical approach also creates vulnerability.

13 Feb 2015

Imperial College London to invest in new facility at Babraham Campus to support dynamic bioscience companies

Imperial College London is to invest in a new facility at the Babraham Research Campus in Cambridge to support spin-out and scale-up companies, and maximise the impact of research from universities.

From Abzena 13 Feb 2015

'Mad Cow' discovery points to possible neuron killing mechanism behind alzheimer’s and parkinson’s diseases

The new study, published recently in the journal Brain, revealed the mechanism of toxicity of a misfolded form of the protein that underlies prion diseases, such as bovine spongiform encephalopathy (“mad cow disease”) and its human equivalent, Creutzfeldt-Jakob disease.

13 Feb 2015

BioMed Realty breaks ground on new 316,000 square foot campus in San Diego

Joined by San Diego political leaders and representatives of the life science community, BioMed Realty Trust, Inc. today broke ground on a new 316,000 square foot laboratory and office campus designed to meet the unique real estate needs of San Diego's thriving life science industry.

13 Feb 2015

NYU study could transform the fields of behavioral brain research, neuropsychobiology

Living in groups affords several benefits for animals, including better feeding opportunities and reduced risks from predators--situations in which critical information is transmitted nonverbally throughout the group.

12 Feb 2015

Researchers identify molecular pathways associated with distinct subsets of SSc patients

For years, doctors have been baffled about why some patients with systemic sclerosis (SSc) respond to therapy while others do not.

12 Feb 2015

USF researchers awarded grant to test new drug for age-related hearing loss

A successful treatment for age-related hearing loss (ARHL) is a step closer to reality, thanks to a group of researchers from the University of South Florida. The research team comprised of faculty and students has been awarded $400,000 by Autifony Therapeutics, Ltd, a company based in the United Kingdom, to test a new drug the company developed for ARHL.

12 Feb 2015

Retigabine drug shows promise in protecting the brain against effects of ischemic stroke

Retigabine, a drug approved to treat epilepsy, protected the brain against the effects of ischemic stroke in a study conducted at The University of Texas Health Science Center at San Antonio.

12 Feb 2015

ORNL's James Roberto elected fellow of Materials Research Society

James Roberto, the associate laboratory director for Science and Technology Partnerships at the Department of Energy's Oak Ridge National Laboratory, has been elected a fellow of the Materials Research Society.

12 Feb 2015

Common protein may play strategic role in tumor growth

A common, yet previously undistinguished protein, which is elevated in many late-stage cancers, may play a strategic role in tumor growth through a non-conventional pathway, researchers at the Indiana University School of Medicine report in the Feb. 10 issue of the Proceedings of the National Academy of Sciences.

12 Feb 2015

Researchers develop novel approach to identify potential antimalarial drugs

Each year nearly 600,000 people--mostly children under age five and pregnant women in sub-Saharan Africa--die from malaria, caused by single-celled parasites that grow inside red blood cells. The most deadly malarial species--Plasmodium falciparum--has proven notoriously resistant to treatment efforts.

12 Feb 2015

UT Southwestern gets NCI grant to establish Heavy Ion Radiation Therapy Research Center in US

UT Southwestern Medical Center is leading a Texas consortium of researchers to establish the country's first National Center for Heavy Ion Radiation Therapy that could provide clinical care and research using heavy particles for innovative new cancer treatments.

12 Feb 2015

AXT establishes preclinical imaging portfolio with MR solutions product lines

To coincide with the start of Lorne Cancer conference, AXT are proud to announce the commencement of their distributorship with MR SOLUTIONS, a world leader in the development of innovative preclinical imaging solutions

From MR Solutions 11 Feb 2015

Cumberland initiates clinical development of Boxaban (ifetroban) oral capsule for AERD treatment

Cumberland Pharmaceuticals Inc. today announced an expansion of its pipeline with a new Phase II development program. The Company has initiated the clinical development of Boxaban (ifetroban) oral capsule for the treatment of aspirin-exacerbated respiratory disease (AERD).

11 Feb 2015

First human clinical study of ChromaDex's NIAGEN nicotinamide riboside meets primary endpoint

ChromaDex Corp. announced today that the initial results of the first human clinical study for the company's NIAGEN nicotinamide riboside (NR) has met its primary endpoint.

11 Feb 2015

IU School of Medicine launches Industry Collaboration Portal

The Indiana University School of Medicine has launched an initiative and accompanying web site to encourage more collaboration between private industry and researchers at the medical school.

11 Feb 2015

Laboratory News and Research

New study indicates that cancer patients rarely push for unnecessary tests, treatments

A*STAR's GIS scientists develop new system that can predict treatment targets for cancer

Recipients of 2015 AACC and NACB Awards announced

Declarative memory helps individuals with neurodevelopmental disorders compensate for dysfunction

Immune system exploits flu virus' dependence on host's machinery

Imperial College London to invest in new facility at Babraham Campus to support dynamic bioscience companies

'Mad Cow' discovery points to possible neuron killing mechanism behind alzheimer’s and parkinson’s diseases

BioMed Realty breaks ground on new 316,000 square foot campus in San Diego

NYU study could transform the fields of behavioral brain research, neuropsychobiology

Researchers identify molecular pathways associated with distinct subsets of SSc patients

USF researchers awarded grant to test new drug for age-related hearing loss

Retigabine drug shows promise in protecting the brain against effects of ischemic stroke

ORNL's James Roberto elected fellow of Materials Research Society

Common protein may play strategic role in tumor growth

Researchers develop novel approach to identify potential antimalarial drugs

UT Southwestern gets NCI grant to establish Heavy Ion Radiation Therapy Research Center in US

AXT establishes preclinical imaging portfolio with MR solutions product lines

Cumberland initiates clinical development of Boxaban (ifetroban) oral capsule for AERD treatment

First human clinical study of ChromaDex's NIAGEN nicotinamide riboside meets primary endpoint

IU School of Medicine launches Industry Collaboration Portal

A guide to density measurement excellence eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics